UK regulator brings new AI and MedTech agenda to AdvaMed

Medicines and Healthcare products Regulatory Agency Version 1 original current

Imported from official source

UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out its next phase of MedTech and AI regulation to US industry leaders at AdvaMed 2026.

This version

Version: 1 of 1
Recorded: October 19, 2026 16:01
Change: Initial
Content hash: d2cc90ec513b45514560ce878c3d6b1c
All versions: Revision history